Thank you very much, and thank you all for your presentations.
My questions are going to be directed to Mr. Eisenschmid and Mr. Emberley for the most part.
In your pan-Canadian pharmacare document, you indicate that a national pharmacare program will result in inappropriate drug therapy. The rationale, as I read through this, is that a closed formulary will limit choice for patients and clinicians' autonomy, and that will negatively impact patient health outcomes.
Every single hospital across Canada uses a closed formulary. Are you basically saying then that hospitals are negatively affecting patient health outcomes by using a closed formulary?